Glyceraldehyde-3-phosphate Dehydrogenase is Activated by Lysine 254 Acetylation in Response to Glucose Signal

Tingting Li,Mengxi Liu,Xu Feng,Zhen Wang,Indrani Das,Yanping Xu,Xin Zhou,Yiping Sun,Kun-Liang Guan,Yue Xiong,Qun-Ying Lei
DOI: https://doi.org/10.1074/jbc.m113.531640
IF: 5.485
2014-01-01
Journal of Biological Chemistry
Abstract:Background: Glyceraldehyde-3-phosphate dehydrogenase is a pivotal glycolytic enzyme and implicated in many human cancers. Results: GAPDH acetylation promotes its activity in response to glucose via the action of PCAF and HDAC5. Conclusion: GAPDH acetylation promotes cell proliferation and tumor growth. Significance: This study demonstrates a critical role of GAPDH acetylation in tumor growth and provides potential therapy target for cancer.The altered metabolism in most tumor cells consists of elevated glucose uptake and increased glycolysis even in the presence of high oxygen tension. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an obligatory enzyme in glycolysis. Here, we report that acetylation at lysine 254 (K254) increases GAPDH activity in response to glucose. Furthermore, acetylation of GAPDH (K254) is reversibly regulated by the acetyltransferase PCAF and the deacetylase HDAC5. Substitution of K254 to glutamine compromises the ability of GAPDH to support cell proliferation and tumor growth. Our study reveals a mechanism of GAPDH enzyme activity regulation by acetylation and its critical role in cellular regulation.
What problem does this paper attempt to address?